← Leaderboards
Rui-Ming Liu
University Of Alabama At Birmingham
$7,365,974
Attributed
$7,365,974
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $761.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,365,974 · 9
By mechanism
R01$3,834,684 · 3
P01$2,273,204 · 2
R56$438,400 · 1
R21$424,188 · 1
P42$395,498 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Dwight J Rouse$18,107,824
- Joanne E Murphy-Ullrich$10,767,443
- Xu Feng$5,639,145
- Chun-Ming Huang$4,262,390
Others in their field
Top investigators on “Lung Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- David Heimbrook · Leidos Biomedical Research, Inc.$251,056,084
- Richard K. Wilson · Washington University$201,818,043
- Richard C Boucher · University Of North Carolina Chapel Hill$113,731,309
- James D Crapo · University Of Colorado Denver$90,634,881
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
Lung DiseasesAnimal ModelAnimalsLungResponseBleomycinProgramsResearch PersonnelProceduresServicesPlayInsightProtocols DocumentationProteinsFibrosisGlutathioneAffectMolecularAgingPrevention StrategyExposure ToBaseEffective TherapyAdenoviruses
Grant awards (30)
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease$432,612
R01 · FY2025 · AG · contact PI
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease$441,440
R01 · FY2024 · AG · contact PI
Core E Research Support$71,417
P42 · FY2024 · NIEHS · contact PI
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease$441,440
R01 · FY2023 · AG · contact PI
Core E Research Support$77,616
P42 · FY2023 · ES · contact PI
Core E Research Support$78,200
P42 · FY2022 · ES · contact PI
Animal Core$197,504
P01 · FY2021 · HL · contact PI
Core E Research Support$77,616
P42 · FY2021 · ES · contact PI
Core E Research Support$90,649
P42 · FY2020 · ES · contact PI
Animal Core$56,168
P01 · FY2020 · HL · contact PI
Animal Core$197,504
P01 · FY2019 · HL · contact PI
Animal Core$197,504
P01 · FY2018 · HL · contact PI
Animal and Therapeutics Core$322,903
P01 · FY2017 · HL · contact PI
PAI-1 and aging-related susceptibility to lung fibrosis$438,400
R56 · FY2016 · HL · contact PI
Animal and Therapeutics Core$322,903
P01 · FY2016 · HL · contact PI
Animal and Therapeutics Core$330,519
P01 · FY2015 · HL · contact PI
Ozone, apoE4, aging, and Alzheimer's disease$20,000
R21 · FY2015 · AG · contact PI
Animal and Therapeutics Core$328,842
P01 · FY2014 · HL · contact PI
Ozone, apoE4, aging, and Alzheimer's disease$183,750
R21 · FY2014 · AG · contact PI
Animal and Therapeutics Core$319,357
P01 · FY2013 · HL · contact PI
Ozone, apoE4, aging, and Alzheimer's disease$220,438
R21 · FY2013 · AG · contact PI
Glutathione and Lung Fibrosis$362,500
R01 · FY2011 · HL · contact PI
Glutathione and Lung Fibrosis$362,500
R01 · FY2010 · HL · contact PI
Glutathione and Lung Fibrosis$349,000
R01 · FY2009 · HL · contact PI
Glutathione and Lung Fibrosis$349,000
R01 · FY2008 · HL · contact PI
Glutathione deficiency & immune dysfunction during aging$210,192
R01 · FY2006 · ES · contact PI
Glutathione deficiency &immune dysfunction during aging$215,250
R01 · FY2005 · ES
Glutathione deficiency &immune dysfunction during aging$215,250
R01 · FY2004 · ES
Glutathione deficiency &immune dysfunction during aging$215,250
R01 · FY2003 · ES
Glutathione deficiency &immune dysfunction during aging$240,250
R01 · FY2002 · ES